ozempic 5 posts

• What happens next following FDA approval of Mounjaro® from Eli Lilly for diabetes?
  22 May 2022  ·  $LLY $NVO diabetes
  The FDA on May 13th approved the dual GIP-GLP1-agonist Mounjaro ® (tirzepatide) from Eli Lilly for diabetes following the completion of the SURPASS studies (e.g. SURPASS-2 NCT03987919 ).
• Novo Nordisk Q2 saw approval of Wegovy® and continued growth of Ozempic® sales
  4 August 2021  ·  Denmark diabetes Eli Lilly
  Novo Nordisk sales and operating profit grew at 12% and 9%, respectively, at constant exchange rates. The FDA approved the once-weekly injectable anti-obesity drug Wegovy® (semaglutide) on June 4th.
• Keytruda®, Ozempic® and the other blockbuster drugs of the 3rd quarter of 2019
  2 November 2019  ·  Biktarvy cross-industry analysis Dupixent
  The pharmaceutical companies AbbVie and Novo Nordisk presented their quarterly results today and concluded the earnings season for the major pharmaceutical companies. There are currently more than 50 blockbuster drugs in the world with annual sales exceeding a billion US dollars. Here the best selli
• Diabetes and the third quarter of 2019
  2 November 2019  ·  diabetes Eli Lilly Europe
  Novo Nordisk and Eli Lilly have both reported their Q3 results. Below are some of the headlines related to their diabetes business.
• Novo Nordisk 2018Q4
  1 February 2019  ·  diabetes Novo Nordisk OMXC25